Patent ID: 7144906

Claim:
A therapeutic pharmaceutical composition for hyperlipidemia, comprising as an active ingredient a heterocyclic compound of the formula [1], or a pharmaceutically acceptable salt thereof: R 1 -Het-D-E [1] wherein: R 1 is aryl; said aryl being optionally substituted by the same or different one to three groups selected from alkyl, haloalkyl, trihaloalkyl, alkoxy, halogen and nitro; Het is an oxazole which is optionally substituted by alkyl or trihaloalkyl; D is alkylene, alkenylene, or alkynylene, and E is a group of the formula [3]: wherein Y is oxygen or sulfur; R 3 is hydrogen or alkyl; p is an integer of 0-2; Z is carboxy, alkoxycarbonyl, hydroxymethyl, carbamoyl, N-hydroxycarbamoyl, N-alkylcarbamoyl, N,N′-dialkylcarbamoyl, cyano, 1H-5-tetrazolyl, 1-alkyl-5-tetrazolyl, or 2-alkyl-5-tetrazolyl; and a pharmaceutically acceptable carrier.